title: Elucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations.
abstract: The insulin-family proteins bind to their own receptors, but insulin-like growth factor II (IGF-II) can also bind to the A isoform of the insulin receptor (IR-A), activating unique and alternative signaling pathways from those of insulin. Although extensive studies of insulin have revealed that its activation is associated with the opening of the B chain-C terminal (BC-CT), the activation mechanism of the insulin-like growth factors (IGFs) still remains unknown. Here, we present the first comprehensive study of the insulin-family proteins comparing their activation process and mechanism using molecular dynamics simulations to reveal new insights into their specificity to the insulin receptor. We have found that all the proteins appear to exhibit similar stochastic dynamics in their conformational change to an active state. For the IGFs, our simulations show that activation involves two opening locations: the opening of the BC-CT section away from the core, similar to insulin; and the additional opening of the BC-CT section away from the C domain. Furthermore, we have found that these two openings occur simultaneously in IGF-I, but not in IGF-II, where they can occur independently. This suggests that the BC-CT section and the C domain behave as a unified domain in IGF-I, but as two independent domains in IGF-II during the activation process, implying that the IGFs undergo different activation mechanisms for receptor binding. The probabilities of the active and inactive states of the proteins suggest that IGF-II is hyperactive compared to IGF-I. The hinge residue and the hydrophobic interactions in the core are found to play a critical role in the stability and activity of IGFs. Overall, our simulations have elucidated the crucial differences and similarities in the activation mechanisms of the insulin-family proteins, providing new insights into the molecular mechanisms responsible for the observed differences between IGF-I and IGF-II in receptor binding.
authors.affiliation: Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.|School of Physics, University of Sydney, Sydney, NSW, Australia.
authors.forename: Anastasios
authors.initials: A
authors.lastname: Papaioannou
authors.affiliation: School of Physics, University of Sydney, Sydney, NSW, Australia.
authors.forename: Serdar
authors.initials: S
authors.lastname: Kuyucak
authors.affiliation: Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.|School of Physics, University of Sydney, Sydney, NSW, Australia.
authors.forename: Zdenka
authors.initials: Z
authors.lastname: Kuncic
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D007328:Insulin / Q000737:chemistry*; D007334:Insulin-Like Growth Factor I / Q000737:chemistry*; D007335:Insulin-Like Growth Factor II / Q000737:chemistry*; D007700:Kinetics; D056004:Molecular Dynamics Simulation; D011485:Protein Binding; D054730:Protein Interaction Domains and Motifs; D017433:Protein Structure, Secondary; D017526:Receptor, IGF Type 1 / Q000737:chemistry*; D017527:Receptor, IGF Type 2 / Q000737:chemistry*; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D013816:Thermodynamics
chemical_list: D007328:Insulin; D017527:Receptor, IGF Type 2; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D017526:Receptor, IGF Type 1